UK Government to fund four studies investigating long COVID
The UK Government will give £18.5 million in funding to four studies researching the causes and potential treatments of long COVID.
List view / Grid view
The UK Government will give £18.5 million in funding to four studies researching the causes and potential treatments of long COVID.
Researchers have found antibodies, from infection with common cold coronaviruses, can also target SARS-CoV-2 - especially in children.
Researchers have studied how the human body responds to viral infection when already infected by fungi, offering insights into the immune system.
A joint research team has demonstrated the possibility of developing a new type of anti-neoplastic drugs based on nanoMIPs...
A derivative of turmeric could be used in eye drops to treat the early stages of glaucoma...
A modified form of botulinum toxin gives long-lasting pain relief in mice without adverse effects...
Scientists are a step closer to understanding which genes are responsible for early-onset Alzheimer's disease in people with Down syndrome...
Detailed brain cell analysis has helped researchers uncover new mechanisms thought to underlie Parkinson's disease...
The first drug targeting the cause of Huntington’s disease was safe and well-tolerated in its first human trial…
Researchers have developed a radioactive ‘tracer’ molecule to detect myeloid-derived suppressor cells’ accumulating in the lung in preparation for the arrival of breast cancer cells...
Medicines are an important part of treating and preventing disease in adults and children. The ideal medicine would have no side effects or adverse drug reactions (ADRs) as they are also called, but the reality is all medicines can cause unwanted effects, in some people.
10 November 2016 | By Niamh Louise Marriott, Digital Content Producer
Researchers have discovered that a marker found on aggressive prostate cancer cells could also be used as a way to guide treatments to the cancer...
15 September 2016 | By Niamh Louise Marriott, Digital Content Producer
Grants of more than €5 million, predominantly from the EU, will be used to develop a new imaging device for the diagnosis of breast cancer...
27 June 2016 | By Victoria White, Digital Content Producer
Eisai and UCL have reached the first scientific milestone in their neurodegenerative disease drug discovery and development collaboration...
9 June 2016 | By Victoria White, Digital Content Producer
Drugs currently being trialled in cancer patients have been used to successfully target an autoimmune condition, uveitis, in mice...